| 2025-12-31 | 2024-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|
Total money the company brought in from its core business during the period, before any costs are subtracted. | – | $0 | $123440 | $3.10M |
Profit from core operations after subtracting the cost of revenue and operating expenses like R&D and marketing, but before interest and taxes. | -$51.97M | -$28.59M | -$18.13M | -$14.77M |
Operating income as a percentage of revenue. | – | – | -14686.2% | -476.2% |
The company's bottom-line profit after all expenses, interest, and taxes are subtracted. | -$48.26M | -$27.52M | -$18.05M | -$14.79M |
Net income divided by the number of shares outstanding — profit attributable to each share. | $-0.49 | $-1.16 | $-0.72 | $-0.81 |
Like basic EPS, but accounts for shares that could be created from stock options or convertible securities — a more conservative per-share profit figure. | $-0.49 | $-1.16 | $-0.72 | – |
| 2025-12-31 | 2024-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|
Everything the company owns that has value — cash, property, inventory, investments, and more. | $181.20M | $98.60M | $24.94M | $42.47M |
All of the company's interest-bearing borrowings, short and long term combined. | – | – | – | $248911 |
Everything the company owes — debt, unpaid bills, and other obligations. | $8.30M | $3.73M | $3.90M | $4.05M |
What would be left for shareholders if the company sold all its assets and paid off all its debts — total assets minus total liabilities. | $172.90M | $94.87M | $21.04M | $38.42M |
| 2025-12-31 | 2024-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|
Actual cash generated by the core business, as opposed to accounting profit, which can include non-cash items. | -$27.79M | -$19.15M | -$17.35M | -$14.30M |
Cash spent on physical assets like property, equipment, and infrastructure to maintain or grow the business. | $13399 | $0 | $243255 | – |
Cash left over after capital expenditures — money the company could use for dividends, buybacks, debt repayment, or reinvestment. | -$27.80M | -$19.15M | -$17.59M | – |